Lung Adenocarcinoma Expressing an EML4‐ALK Fusion Transcript With Premature Stop Codons and Response to Alectinib: A Case Report.

ALK fusions are well‐established oncogenic drivers in lung cancer, typically resulting in ALK activation through dimerization mediated by partner proteins. However, alternative mechanisms of ALK activation have also been reported. We herein report an 80‐year‐old man with metastatic lung adenocarcino...

Descripción completa

Detalles Bibliográficos

Publicado en:	Thoracic Cancer Vol. 16; no. 15; pp. 1 - 5
Autores principales:	Ozaki, Mami, Ikushima, Hiroaki, Suzuki, Masaki, Yokoyama, Akira, Fukuda, Kensuke, Watanabe, Kousuke, Shinozaki‐Ushiku, Aya, Kato, Motohiro, Ushiku, Tetsuo, Aburatani, Hiroyuki, Oda, Katsutoshi, Kage, Hidenori
Formato:	case study diagnostic images pictorial tables/charts Journal Article
Publicado:	Wiley-Blackwell Aug2025
Acceso en línea:	Ver este registro en EBSCOhost